{
  "case_id": "Case_6",
  "model_id": "perplexity/sonar-deep-research",
  "content": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Acute decompensated heart failure\",\n        \"confidence\": 0.85,\n        \"icd_code\": \"I50.9\",\n        \"reasoning\": \"Classic triad of progressive dyspnea, fatigue, and bilateral edema with elevated JVP and pulmonary crackles in patient with diabetes and hypertension risk factors\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Cardiogenic pulmonary edema\",\n            \"confidence\": 0.75,\n            \"icd_code\": \"J81.0\",\n            \"reasoning\": \"Acute onset respiratory symptoms with crackles and elevated JVP suggest fluid redistribution to lungs\"\n        },\n        {\n            \"name\": \"Acute coronary syndrome with heart failure\",\n            \"confidence\": 0.65,\n            \"icd_code\": \"I21.9\",\n            \"reasoning\": \"Chest discomfort in diabetic patient could indicate silent MI precipitating heart failure\"\n        },\n        {\n            \"name\": \"Diabetic cardiomyopathy\",\n            \"confidence\": 0.60,\n            \"icd_code\": \"E11.40\",\n            \"reasoning\": \"Type 2 diabetes is independent risk factor for heart failure through direct cardiac effects\"\n        }\n    ],\n    \"key_findings\": [\n        \"Bilateral lower extremity edema with elevated jugular venous pressure\",\n        \"Progressive dyspnea with bibasilar pulmonary crackles\",\n        \"History of diabetes and hypertension as heart failure risk factors\",\n        \"Communication barrier requiring immediate interpreter services\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"BNP or NT-proBNP\",\n            \"purpose\": \"Confirm heart failure diagnosis with high sensitivity and specificity\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Chest X-ray\",\n            \"purpose\": \"Assess for pulmonary edema, cardiomegaly, pleural effusions\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"12-lead ECG\",\n            \"purpose\": \"Rule out acute MI, assess for arrhythmias, LV hypertrophy\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Echocardiogram\",\n            \"purpose\": \"Assess ejection fraction, wall motion, valvular function\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Comprehensive metabolic panel\",\n            \"purpose\": \"Assess kidney function, electrolytes, glucose control\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Troponin I or T\",\n            \"purpose\": \"Rule out acute myocardial infarction\",\n            \"priority\": \"immediate\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Arrange qualified ASL interpreter immediately for proper communication\",\n            \"Obtain IV access and continuous cardiac monitoring\",\n            \"Position patient in semi-upright position to improve breathing\",\n            \"Administer supplemental oxygen if oxygen saturation <90%\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Furosemide\",\n                \"dose\": \"40mg\",\n                \"route\": \"IV\",\n                \"duration\": \"Initial dose, then titrate based on response\",\n                \"rationale\": \"Loop diuretic for fluid overload and pulmonary congestion\"\n            },\n            {\n                \"drug\": \"Lisinopril\",\n                \"dose\": \"2.5-5mg\",\n                \"route\": \"PO\",\n                \"duration\": \"Daily, titrate to maximum tolerated dose\",\n                \"rationale\": \"ACE inhibitor for heart failure management and mortality benefit\"\n            },\n            {\n                \"drug\": \"Metoprolol succinate\",\n                \"dose\": \"12.5-25mg\",\n                \"route\": \"PO\",\n                \"duration\": \"Twice daily, start low and titrate up\",\n                \"rationale\": \"Beta-blocker for heart failure mortality benefit once stable\"\n            }\n        ],\n        \"monitoring\": [\n            \"Daily weights and fluid balance\",\n            \"Blood pressure and heart rate every 4 hours\",\n            \"Oxygen saturation continuous monitoring\",\n            \"Kidney function and electrolytes in 24-48 hours\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Cardiology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"New diagnosis of heart failure requiring specialist evaluation and optimization\"\n            },\n            {\n                \"specialty\": \"Endocrinology\",\n                \"urgency\": \"routine\",\n                \"reason\": \"Diabetes management optimization in setting of heart failure\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Worsening respiratory distress or hypoxemia\",\n        \"Chest pain suggesting acute coronary syndrome\",\n        \"Acute kidney injury from diuretic therapy\",\n        \"Symptomatic hypotension\",\n        \"New arrhythmias\"\n    ],\n    \"patient_education\": [\n        \"Heart failure diagnosis and importance of medication compliance\",\n        \"Daily weight monitoring and fluid restriction guidelines\",\n        \"Recognition of worsening symptoms requiring immediate medical attention\",\n        \"Importance of blood pressure and diabetes control\",\n        \"Dietary sodium restriction recommendations\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"1-2 weeks after discharge or within 7 days if outpatient management\",\n        \"conditions\": \"Return immediately for worsening shortness of breath, chest pain, weight gain >3 pounds in 24 hours or >5 pounds in week, dizziness, or palpitations\"\n    },\n    \"confidence_in_assessment\": 0.75,\n    \"uncertainties\": [\n        \"Incomplete history due to communication barriers may have missed important details\",\n        \"Unclear if this represents new-onset heart failure or exacerbation of existing condition\",\n        \"Degree of left ventricular dysfunction unknown without echocardiogram\",\n        \"Potential medication interactions or contraindications not fully assessed due to limited history\"\n    ]\n}",
  "latency": 60.23984098434448,
  "timestamp": "2025-08-10T01:29:32.873831",
  "cached_at": "2025-08-10T01:29:32.873838"
}